• Hao Zhou, Ken Chang, Harrison X Bai, Bo Xiao, Chang Su, Wenya Linda Bi, Paul J Zhang, Joeky T Senders, Martin Vallières, Vasileios K Kavouridis, Alessandro Boaro, Omar Arnaout, Li Yang, and Raymond Y Huang.
• Department of Neurology, Xiangya Hospital of Central South University, Changsha, Hunan, China.
• J. Neurooncol. 2019 Apr 1; 142 (2): 299-307.

PurposeIsocitrate dehydrogenase (IDH) and 1p19q codeletion status are importantin providing prognostic information as well as prediction of treatment response in gliomas. Accurate determination of the IDH mutation status and 1p19q co-deletion prior to surgery may complement invasive tissue sampling and guide treatment decisions.MethodsPreoperative MRIs of 538 glioma patients from three institutions were used as a training cohort. Histogram, shape, and texture features were extracted from preoperative MRIs of T1 contrast enhanced and T2-FLAIR sequences. The extracted features were then integrated with age using a random forest algorithm to generate a model predictive of IDH mutation status and 1p19q codeletion. The model was then validated using MRIs from glioma patients in the Cancer Imaging Archive.ResultsOur model predictive of IDH achieved an area under the receiver operating characteristic curve (AUC) of 0.921 in the training cohort and 0.919 in the validation cohort. Age offered the highest predictive value, followed by shape features. Based on the top 15 features, the AUC was 0.917 and 0.916 for the training and validation cohort, respectively. The overall accuracy for 3 group prediction (IDH-wild type, IDH-mutant and 1p19q co-deletion, IDH-mutant and 1p19q non-codeletion) was 78.2% (155 correctly predicted out of 198).ConclusionUsing machine-learning algorithms, high accuracy was achieved in the prediction of IDH genotype in gliomas and moderate accuracy in a three-group prediction including IDH genotype and 1p19q codeletion.

40 keywords...

hide…